Search

Your search keyword '"Houeto, J.L."' showing total 23 results
Start Over Author "Houeto, J.L."
23 results on '"Houeto, J.L."'

1. Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial

Author

Welter, M.L., Cuny, E., Derkinderen, P., Fontaine, D., Houeto, J.L., Jalenques, I., Mallet, L., Pollak, P., Thobois, S., Bissery, A., Oya, H., Bardinet, E., Yelnik, J., Buot, A., Czernecki, V., du Montcel, S. Tezenas, Tanguy, A., Hajji, M., Karachi, C., Hartmann, A., Agid, Y., Worbe, Y., Dormont, D., Vidailhet, M., Cornu, P., Aouizerate, B., Burbaud, P., Durif, F., Fauchon, C., Rondepierre, F., Derost, P., Aya Kombo, M., Polosan, M., Chabardès, S., Krainik, A., Krack, P., Piallat, B., Guenot, M., Poulet, E., Klinger, H., Serra, G., Broussolle, E., Rouaud, T., Sauvaget, A., Damier, P., Raoul, S, Borg, M., Giordana, B., Magnie-Mauro, M.-N., Jaafari, N., Bataille, B., Ansquer, S., Benatru, I., Fradet, A., Dugast, E., Ouerdani, A., Rabois, E., Quintin, M., Palfi, S., Welter, Marie-Laure, Houeto, Jean-Luc, Thobois, Stéphane, Bataille, Benoit, Guenot, Marc, Worbe, Yulia, Hartmann, Andreas, Czernecki, Virginie, Bardinet, Eric, Yelnik, Jerome, du Montcel, Sophie Tezenas, Agid, Yves, Vidailhet, Marie, Cornu, Philippe, Tanguy, Audrey, Ansquer, Solène, Jaafari, Nematollah, Poulet, Emmanuel, Serra, Giulia, Burbaud, Pierre, Cuny, Emmanuel, Aouizerate, Bruno, Pollak, Pierre, Chabardes, Stephan, Polosan, Mircea, Borg, Michel, Fontaine, Denys, Giordana, Bruno, Raoul, Sylvie, Rouaud, Tiphaine, Sauvaget, Anne, Jalenques, Isabelle, Karachi, Carine, and Mallet, Luc

Published
2017
Full Text
View/download PDF

4. Parkinson's disease with camptocormia

Author

Bloch, F., Houeto, J.L., Tezenas du Montcel, S., Bonneville, F., Etchepare, F., Welter, M.L., Rivaud-Pechoux, S., Hahn-Barma, V., Maisonobe, T., Behar, C., Lazennec, J.Y., Kurys, E., Arnulf, I., Bonnet, A.M., and Agid, Y.

Subjects
Parkinson's disease -- Research, Parkinson's disease -- Health aspects, Posture disorders -- Research, Posture disorders -- Causes of, Posture disorders -- Physiological aspects, Health, Psychology and mental health
Published
2006

5. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up

Author

Schupbach, W.M.M., Chastan, N., Welter, M.L., Houeto, J.L., Mesnage, V., Bonnet, A.M., Czernecki, V., Maltete, D., Hartmann, A., Mallet, L., Pidoux, B., Dormont, D., Navarro, S., Cornu, P., Mallet, A., and Agid, Y.

Subjects
Thalamus -- Physiological aspects, Parkinson's disease -- Care and treatment, Dopa -- Complications and side effects, Brain stimulation -- Patient outcomes, Brain stimulation -- Research, Health, Psychology and mental health
Published
2005

7. Behavioural disorders, Parkinson's disease and subthalamic stimulation. (Paper)

Author

Houeto, J.L., Mesnage, V., Mallet, L., Pillon, B., Gargiulo, M., Moncel, S. Tezenas Du, Bonnet, A.M., Pidoux, B., Dormont, D., Cornu, P., and Agid, Y.

Subjects
Social aspects, Physiological aspects, Measurement, Parkinson disease -- Physiological aspects -- Measurement -- Social aspects, Social adjustment -- Measurement -- Social aspects -- Physiological aspects, Disabilities -- Social aspects -- Measurement -- Physiological aspects, Physically disabled persons -- Social aspects -- Physiological aspects -- Measurement, Disability -- Social aspects -- Measurement -- Physiological aspects, Parkinson's disease -- Physiological aspects -- Measurement -- Social aspects
Abstract

Objective: to analyse 24 parkinsonian patients successfully treated by bilateral STN stimulation for the presence of behavioural disorders. Method: patients were evaluated retrospectively for adjustment disorders (social adjustment scale, SAS), [...]

Published
2002

11. Neurostimulation for Parkinson's Disease with Early Motor Complications

Author

Schuepbach, W.M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Halbig, T.D., Hesekamp, H., Navarro, S.M., Meier, N., Falk, D., Mehdorn, M., Paschen, S., Maarouf, M., Barbe, M.T., Fink, G.R., Kupsch, A., Gruber, D., Schneider, G.H., Seigneuret, E., Kistner, A., Chaynes, P., Ory-Magne, F., Brefel Courbon, C., Vesper, J., Schnitzler, A., Wojtecki, L., Houeto, J.L., Bataille, B., Maltete, D., Damier, P., Raoul, S., Sixel-Doering, F., Hellwig, D., Gharabaghi, A., Kruger, R., Pinsker, M.O., Amtage, F., Regis, J.M., Witjas, T., Thobois, S., Mertens, P., Kloss, M., Hartmann, A., Oertel, W.H., Post, B., Speelman, H., Agid, Y., Schade-Brittinger, C., Deuschl, G., Neurology, Krack, Paul, and Diener, Hans Christoph (Beitragende*r)

Subjects
Adult, Male, medicine.medical_specialty, Parkinson's disease, DCN MP - Plasticity and memory, medicine.medical_treatment, Medizin, Electric Stimulation Therapy, 610 Medicine & health, Implantable Neurostimulators/adverse effects, law.invention, Antiparkinson Agents, Randomized controlled trial, Quality of life, Subthalamic Nucleus, law, Surveys and Questionnaires, Internal medicine, Activities of Daily Living, Dopamine Agonists/adverse effects/therapeutic use, Clinical endpoint, Humans, Medicine, Adverse effect, Neurostimulation, Electric Stimulation Therapy/adverse effects, Dyskinesias, Quality of Life, Intention-to-treat analysis, business.industry, Parkinson Disease, General Medicine, Middle Aged, medicine.disease, Combined Modality Therapy, Intention to Treat Analysis, Implantable Neurostimulators, Parkinson Disease/drug therapy/physiopathology/*therapy, Treatment Outcome, Dyskinesia, Dopamine Agonists, Antiparkinson Agents/adverse effects/therapeutic use, Physical therapy, Female, medicine.symptom, business, Dyskinesias/etiology
Abstract

Item does not contain fulltext BACKGROUND: Subthalamic stimulation reduces motor disability and improves quality of life in patients with advanced Parkinson's disease who have severe levodopa-induced motor complications. We hypothesized that neurostimulation would be beneficial at an earlier stage of Parkinson's disease. METHODS: In this 2-year trial, we randomly assigned 251 patients with Parkinson's disease and early motor complications (mean age, 52 years; mean duration of disease, 7.5 years) to undergo neurostimulation plus medical therapy or medical therapy alone. The primary end point was quality of life, as assessed with the use of the Parkinson's Disease Questionnaire (PDQ-39) summary index (with scores ranging from 0 to 100 and higher scores indicating worse function). Major secondary outcomes included parkinsonian motor disability, activities of daily living, levodopa-induced motor complications (as assessed with the use of the Unified Parkinson's Disease Rating Scale, parts III, II, and IV, respectively), and time with good mobility and no dyskinesia. RESULTS: For the primary outcome of quality of life, the mean score for the neurostimulation group improved by 7.8 points, and that for the medical-therapy group worsened by 0.2 points (between-group difference in mean change from baseline to 2 years, 8.0 points; P=0.002). Neurostimulation was superior to medical therapy with respect to motor disability (P

Published
2013
Full Text
View/download PDF

12. TouretteEs syndrome and deep brain stimulation

Author

Houeto, J.L., Karachi, C., Mallet, L., Pillon, B., Yelnik, J., Mesnage, V., Welter, M.L., Navarro, S., Pelissolo, A., Damier, P., Pidoux, B., Dormont, D., Cornu, P., and Agid, Y.

Subjects
Tourette's syndrome -- Care and treatment, Tourette's syndrome -- Patient outcomes, Tourette's syndrome -- Case studies, Brain stimulation -- Patient outcomes, Brain stimulation -- Case studies, Health, Psychology and mental health
Published
2005

13. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.

Author

Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., Vuillaume, I., Corvol, J.C., Brefel-Courbon, C., Ory-Magne, F., Guehl, D., Eusebio, A., Fraix, V., Saulnier, P.J., Lagha-Boukbiza, O., Durif, F., Faighel, M., Giordana, C., Drapier, S., Maltete, D., Tranchant, C., Houeto, J.L., Debû, B.H.G., Sablonniere, B., Azulay, J.P., Tison, F., Rascol, O., Vidailhet, M., Destee, A., Bloem, B.R., Bordet, R., Devos, D., Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., Vuillaume, I., Corvol, J.C., Brefel-Courbon, C., Ory-Magne, F., Guehl, D., Eusebio, A., Fraix, V., Saulnier, P.J., Lagha-Boukbiza, O., Durif, F., Faighel, M., Giordana, C., Drapier, S., Maltete, D., Tranchant, C., Houeto, J.L., Debû, B.H.G., Sablonniere, B., Azulay, J.P., Tison, F., Rascol, O., Vidailhet, M., Destee, A., Bloem, B.R., Bordet, R., and Devos, D.

Abstract

1 juli 2012, Item does not contain fulltext, BACKGROUND: Despite optimum medical management, many patients with Parkinson's disease are incapacitated by gait disorders including freezing of gait. We aimed to assess whether methylphenidate--through its combined action on dopamine and noradrenaline reuptake--would improve gait disorders and freezing of gate in patients with advanced Parkinson's disease without dementia who also received subthalamic nucleus stimulation. METHODS: This multicentre, parallel, double-blind, placebo-controlled, randomised trial was done in 13 movement disorders departments in France between October, 2009, and December, 2011. Eligible patients were younger than 80 years and had Parkinson's disease, severe gait disorders, and freezing of gate despite optimised treatment of motor fluctuations with dopaminergic drugs and subthalamic stimulation. We randomly assigned patients (1:1 with a computer random-number generator in blocks of four) to receive methylphenidate (1 mg/kg per day) or placebo capsules for 90 days. Patients, their carers, study staff, investigators, and data analysts were masked to treatment allocation. To control for confounding effects of levodopa we assessed patients under standardised conditions with an acute levodopa challenge. Our primary outcome was a change in the number of steps during the stand-walk-sit (SWS) test without levodopa. We compared the respective mean numbers of steps at day 90 in the methylphenidate and placebo groups in a covariance analysis and adjusted for baseline differences. This trial is registered with ClinicalTrials.gov, number NCT00914095. FINDINGS: We screened 81 patients and randomly assigned 35 to receive methylphenidate and 34 to receive placebo. 33 patients in the methylphenidate group and 32 patients in the placebo group completed the study. Efficacy outcomes were assessed in the patients who completed the study. Compared with patients in the placebo group (median 33 steps [IQR 26-45]), the patients in the methylphenidate group made f

Published
2012

20. Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up

Author

Lang, A.E., primary, Kleiner-Fisman, G., additional, Saint-Cyr, J.A., additional, Miyasaki, J., additional, Lozano, A., additional, Houeto, J.L., additional, Mesnage, V., additional, Welter, M.L., additional, Mallet, L., additional, Agid, Y., additional, Bejjani, B.P., additional, Berney, A., additional, Ghika, J., additional, Villemure, J.G., additional, and Vingerhoets, F.J. G., additional

Published
2003
Full Text
View/download PDF

22. Le méthylphenidate améliore le freezing de la marche chez les patients parkinsoniens sous stimulation subthalamicque: Une étude randomisée contre placébo

Author

Moreau, C., Delval, A., Dujardin, K., Duhamel, A., Kreisler, Alexandre, Petyt, G., Hossein Foucher, C., Warembourg, F., Brudowski, M., Thavarak, O., Simonin, C., Mutez, E., Destée, A., Bordet, R., Defebvre, L., Devos, David, Walter, Grabli, D., Arguilliere, S., Hesekamp, H., Cohelo Braga, M.C., Girault, N., Chucha, Corvol, J.C., Vidailhet, M., Toulouse, Brefel-Courbon, C., Ory-Magne, F., Rascol, O., Bordeaux, Guehl, D., Tison, F., Marseille, Eusebio, A., Witjas, T., Fluchere, F., Azulay, J.P., Grenoble, Fraix, V., Debû, B., Pollak, P., Krack, P., Strasbourg, Tranchant, C., Lagacha-Boukbiza, O., Poitiers, Houeto, J.L., Nantes, Derkinderen, P., Faighel, M., Renou, P., Damier, P., Giordana, C., Borg, M., Rennes, Drapier, S., Verin, M., Clermont Ferrand, Debilly, B., Durif, F., Rouen, Lefaucheur, R., Maltete, D., Caen, Defer, G., Amiens, and Krystkowiak, P.

Published
2012
Full Text
View/download PDF

23. Behavioural disorders, Parkinson's disease and subthalamic stimulation

Author

Cornu, P., Houeto, J.L., Agid, Y., Mesnage, V., Mallet, L., Pillon, B., Gargiulo, M., Moncel, S.T. du, Bonnet, A.M., Pidoux, B., and Dormont, D.

Abstract

OBJECTIVE: to analyse 24 parkinsonian patients successfully treated by bilateral STN stimulation for the presence of behavioural disorders. METHOD: patients were evaluated retrospectively for adjustment disorders (social adjustment scale, SAS), psychiatric disorders (comparison of the results of psychiatric interview and the mini international neuropsychiatric inventory) and personality changes (IOWA scale of personality changes). RESULTS: parkinsonian motor disability was improved by 69.5% and the levodopa equivalent daily dosage was reduced by 60.5%. Social adjustment (SAS) was considered good or excellent in nine patients, moderately (n=14), or severely (n=1) impaired in 15 patients. Psychiatric disorders consisted of amplification or decompensation of previously existing disorders that had sometimes passed unnoticed, such as depressive episodes (n=4), generalised anxiety (n=18), and behavioural disorders with drug dependence (n=2). Appearance of mild to moderate emotional hyperreactivity was reported in 15 patients. Personality traits (IOWA scale) were improved in eight patients, unchanged in seven, and aggravated in eight CONCLUSION: Improvement in parkinsonian motor disability induced by STN stimulation is not necessarily accompanied by improvement in psychic function and quality of life. Attention is drawn to the possible appearance of personality disorders and decompensation of previous psychiatric disorders in parkinsonian patients who are suitable candidates for neurosurgery. We suggest that a careful psychological and psychiatric interview be performed before surgery, and emphasise the need for psychological follow up to ensure the best possible outcome.

Published
2002

Catalog

Books, media, physical & digital resources
See catalog results